Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/12/2026

Chest Tube Management for Pneumothorax and Pleural Effusion

Pneumothorax Management

  • For most clinically stable patients with large pneumothorax, the American Thoracic Society recommends using 16F to 22F standard chest tubes 1, 2
  • For unstable patients or those requiring mechanical ventilation with large pneumothorax, the American Thoracic Society suggests using 24F to 28F chest tubes 2, 3
  • The American College of Chest Physicians recommends that larger tubes (>28F) are generally not necessary for pneumothorax management 2
  • For small pneumothoraces in stable patients, small-bore catheters (≤14F) may be acceptable 1
  • The American Thoracic Society recommends observation alone may be appropriate for clinically stable patients with small pneumothoraces 4, 5

Pleural Effusion Management

  • The European Respiratory Society recommends positioning the tube at the dependent portion of the effusion, typically the posterior basal area, for pleural effusion management 6

Special Considerations

  • For unstable patients with pneumothorax of any size, the American College of Chest Physicians recommends chest tube placement as mandatory 2
  • The American Thoracic Society suggests that unstable patients should be hospitalized with insertion of a chest tube to reexpand the lung 1
  • For ventilated patients, the European Respiratory Society recommends considering clamping the ventilator circuit before accessing the pleural space to prevent spreading of air or fluid 6

Drainage Systems

  • The American College of Chest Physicians recommends connecting all chest tubes to an appropriate drainage system, such as a water seal device (with or without suction) 1, 2
  • The American Thoracic Society suggests using a Heimlich valve for selected cases 7

Chest Tube Removal

  • The American College of Chest Physicians recommends removing tubes in a staged manner to ensure air leaks have resolved 7
  • The American Thoracic Society suggests discontinuing suction and confirming resolution of pneumothorax on chest radiograph before removal 7

Complications to Monitor

  • The American Journal of Respiratory and Critical Care Medicine reports that pain is more common with larger tubes 4
  • The American College of Chest Physicians notes that tube blockage is more common with small-bore tubes 2

Chest Tube Management for Minimal Hemopneumothorax

Decision Algorithm Based on Clinical Stability and Size

  • For clinically stable patients with a small pneumothorax component (<3 cm), observation in the emergency department for 3-6 hours with repeat chest radiograph is appropriate, and discharge home if no progression, with follow-up within 12 hours to 2 days, as recommended by the American College of Chest Physicians 8
  • The American College of Chest Physicians recommends that chest tube placement is not appropriate for most clinically stable patients with a small pneumothorax component (<3 cm) 8
  • For clinically stable patients with a large pneumothorax component (≥3 cm), chest tube placement is indicated, and a small-bore catheter (≤14F) or 16F-22F chest tube should be used, according to the American College of Chest Physicians 8
  • Hospitalization is recommended for most instances of clinically stable patients with a large pneumothorax component (≥3 cm), as suggested by the American College of Chest Physicians 8
  • For clinically unstable patients, chest tube placement is mandatory regardless of size, and a 16F-22F chest tube should be used for most unstable patients, as recommended by the American College of Chest Physicians 8
  • Immediate hospitalization is required for clinically unstable patients, according to the American College of Chest Physicians 8

Critical Definitions for Decision-Making

  • Clinical stability requires a respiratory rate <24 breaths/min, heart rate 60-120 beats/min, normal blood pressure, room air oxygen saturation >90%, and the ability to speak in whole sentences between breaths, as defined by the American College of Chest Physicians 8

Common Pitfalls to Avoid

  • The American Thoracic Society recommends that chest tube placement should not be done reflexively for "minimal" findings, and observation is safer and avoids unnecessary pain and complications if the patient is stable 9
  • Close monitoring during the observation period is necessary, including repeat imaging to exclude progression, ensuring reliable follow-up is available, and admitting patients who live far from emergency services, as recommended by the American College of Chest Physicians 8, 9

Management of Pneumothorax: When to Avoid Closed Tube Thoracostomy

Introduction to Pneumothorax Management

  • The American Thoracic Society recommends that chest tube insertion should be avoided in clinically stable patients with small pneumothoraces (<2 cm or apical), as observation alone is safer and prevents unnecessary pain and complications 10, 11

Absolute Situations to Avoid Chest Tube Placement

  • Clinically stable patients with small pneumothoraces (defined as <2 cm from chest wall or apical only) should not receive chest tube placement, as the risks outweigh benefits 10, 11
  • The American College of Chest Physicians suggests that these patients should be observed in the outpatient setting with close follow-up rather than subjected to invasive procedures 10, 11

Relative Contraindications Requiring Careful Consideration

  • The American Thoracic Society recommends that simple aspiration should be attempted first for primary pneumothoraces <2 cm in clinically stable patients before considering chest tube placement 11
  • Chest tube placement is inappropriate as initial management for most clinically stable patients with small primary pneumothoraces 11

Special Populations Requiring Modified Approach

  • Patients with cystic fibrosis and small pneumothoraces who are clinically stable should not routinely receive chest tube placement, as the pain associated with chest tube placement may outweigh benefits 10
  • The American Thoracic Society suggests that observation with close monitoring is more appropriate in this population when clinically stable 10
  • Patients with previous thoracic surgery are not contraindicated to chest tube placement, but may have pleural adhesions making placement more technically challenging 11
  • Image guidance should be strongly considered in patients with previous thoracic surgery 12

Critical Pitfalls to Avoid

  • The American College of Chest Physicians strongly opposes emergency department management with immediate chest tube for small pneumothoraces in stable patients 11
  • Patients should not be referred for thoracoscopy without prior stabilization with chest tube if intervention is needed 11
  • Consider reliability of patient and family, and ease of access to healthcare when deciding between observation versus intervention 10

Chest‑Tube Management and Pleurodesis Guidelines

1. Indications for Chest‑Tube Placement

  • Unstable patients with a pneumothorax of any size require immediate chest‑tube drainage and hospital admission (American College of Chest Physicians recommendation) 13.
  • Mechanically ventilated patients who develop a pneumothorax also need chest‑tube drainage to prevent significant air leaks 13.

2. Size Selection of the Drain

  • Unstable or mechanically ventilated pneumothorax: use large‑bore tubes (24–28 F) (Chest Society guidance) 13.
  • Stable large pneumothorax (≥3 cm): 16–22 F tubes are adequate; a small catheter (≤14 F) may be used in selected stable patients, acknowledging a higher risk of occlusion 13.
  • Tubes larger than 28 F are generally unnecessary for pneumothorax (Chest Society) 13.
  • Pleural effusion: small‑bore catheters (8–16 F) achieve success rates comparable to large‑bore tubes (American Thoracic Society evidence) 14.
  • Hemothorax: larger tubes (16–28 F) are preferred to reduce clot obstruction; pigtail catheters are not standard (Chest Society) 13.

3. Insertion Technique

  • Perform an incisional approach; avoid the use of a trocar to prevent catastrophic organ injury (Chest Society) 13.
  • After insertion, obtain a post‑procedure chest radiograph to confirm tube position and lung re‑expansion (Chest Society) 15.

4. Drainage System Configuration

  • Connect all chest tubes to a water‑seal system; use suction (−20 cm H₂O) when lung re‑expansion is incomplete (moderate consensus) 13.
  • If the lung fails to re‑expand, add suction to the water‑seal system (good consensus) 13.
  • Heimlich valves may be employed in selected cases, but a water‑seal system remains the preferred option (Chest Society) 13.
  • Apply suction of 20 cm H₂O until 24‑hour output falls below 150 mL (American Thoracic Society guideline) 14.

5. Maintenance of Tube Patency

  • Maintain tube patency without breaking the sterile field (Class I, Level B) 16.
  • Do not “milk” or manually squeeze the tube (Class IIIA, Level B, randomized evidence) 16.
  • Do not breach sterility to aspirate or mechanically clear obstructions (Class IIIA, Level B) 16.
  • Use active‑cleaning systems with an internal guidewire loop to dissolve clots while preserving sterility (Innovation 2023) 16.

6. Criteria for Chest‑Tube Removal

  • 24‑hour drainage <150 mL, no air leak, and complete radiographic lung re‑expansion are required before removal (Chest Society) [14][15].
  • After the last documented air leak, clamp the tube for ~4 hours, obtain a repeat chest radiograph, and then remove the tube if the lung remains fully expanded (Chest Society) 15.

7. Management of Persistent Air Leaks

  • Observe for up to 4 days to allow spontaneous closure of a bronchopleural fistula (Chest Society) 15.
  • If the leak persists beyond 4 days, refer for thoracoscopic surgery (very good consensus) [15][13].
  • Do not place an additional chest tube or perform bronchoscopy solely to seal endobronchial leaks (Chest Society) 15.
  • Chemical pleurodesis via the chest tube is generally not recommended unless surgery is contraindicated (Chest Society) 15.

8. Pleurodesis for Recurrent Malignant Effusions

  • Indicated for symptomatic patients with recurrent malignant pleural effusion (American Thoracic Society) 14.
  • Talc is the most effective sclerosant, achieving 93 % success (153/165 patients) (American Thoracic Society) 14.
  • Other agents and their success rates:

    Agent Success Rate
    Corynebacterium parvum 76 %
    Doxycycline 72 %
    Tetracycline 67 %
    Bleomycin 54 %
  • Pleurodesis can be performed through small catheters (8–16 F) with outcomes comparable to large tubes (American Thoracic Society) 14.
  • Standard pleurodesis technique: confirm lung re‑expansion radiographically, provide narcotic analgesia, instill sclerosant in 50–100 mL sterile saline, clamp the tube for 1 hour, reconnect to suction 20 cm H₂O, and maintain suction until 24‑hour output <150 mL (American Thoracic Society) 14.
  • If the patient is on systemic corticosteroids, reduce or discontinue them when possible to improve sclerosant efficacy (American Thoracic Society) 14.
  • Pain is the most common adverse effect of sclerosants, especially doxycycline; fever is also frequent (American Thoracic Society) 14.

9. Prevention of Recurrent Pneumothorax

  • Primary pneumothorax: most experts reserve preventive interventions for the second episode (85 % of panel) (Chest Society) 15; 15 % would intervene after the first episode (Chest Society) 15.
  • Secondary pneumothorax: 81 % recommend intervention after the first occurrence due to higher mortality risk (Chest Society) 13; 19 % would wait until the second episode (Chest Society) 13.
  • Thoracoscopic surgery is the preferred preventive strategy (very good consensus) (Chest Society) [15][13].
  • Reported surgical success rates: 95–100 % for thoracoscopy vs 78–91 % for chemical pleurodesis (Chest Society) 15.
  • Bullectomy with stapler is the preferred operative technique (Chest Society) 17.
  • Acceptable pleurodesis methods to achieve pleural symphysis include parietal pleurectomy, talc poudrage, and limited parietal abrasion (Chest Society) 17.

10. Digital Drainage Systems (Innovation 2023)

  • Digital systems provide automated quantitative monitoring of air leaks and fluid output.
  • In cardiac surgery patients, digital drainage reduced the need for follow‑up chest radiographs to detect air leaks (8.6 % vs 20.2 %, p < 0.01) (Innovation 2023) 18.
  • A randomized trial (2021, 520 cardiac surgery patients) showed that active‑cleaning reduced re‑exploration for bleeding by 72 % (5.7 % vs 1.6 %, p = 0.01) and complete tube occlusion by 89 % (2 % vs 19 %, p = 0.01) (Innovation 2023) [18][16].
  • Propensity‑matched analysis demonstrated that active cleaning decreased drainage procedures for pleural effusions (8.1 % vs 22 %, p < 0.001), post‑operative atrial fibrillation (25 % vs 37 %, p = 0.011), and shortened ICU and hospital stays (Innovation 2023) 16.

Indications and Best Practices for Chest Tube Drainage

Parapneumonic Effusions and Empyema

  • A pleural fluid pH < 7.20 is an absolute indication for immediate chest‑tube drainage in patients with parapneumonic effusion or empyema. 19
  • The presence of gross pus in pleural fluid mandates chest‑tube drainage regardless of measured pH. 19
  • Loculated pleural collections should be drained early because they are associated with a poorer prognosis compared with free‑flowing effusions. 19
  • Large pleural effusions occupying more than 40 % of a hemithorax often require surgical intervention and should be drained to provide symptomatic relief. 19

Malignant Pleural Effusions

  • Recurrent, symptomatic malignant pleural effusions are an indication for chest‑tube drainage combined with pleurodesis to improve dyspnea and quality of life. 20
  • Diagnostic thoracentesis is recommended in patients suspected of malignant effusion, especially when systemic oncologic therapy is being considered. 21
  • For recurrent malignant effusions, placement of an indwelling pleural catheter is advised to reduce repeated hospital admissions and drainage procedures. 21

Pleural Infection

  • When pleural infection is suspected, initial thoracentesis and fluid analysis are required; confirmed infection should be managed with chest‑tube drainage. [21][19]
  • Management of pleural infection should involve a pulmonologist or thoracic surgeon to ensure appropriate drainage technique and follow‑up. 19

Post‑operative Prophylactic Drainage

  • After thoracic surgery, prophylactic drainage of air, blood, and other fluids is standard practice to prevent postoperative complications.
  • In cardiac surgery, the primary concern for prophylactic drainage is the accumulation of blood, which serves as a marker for hemorrhage and risk of postoperative complications. [22][23]

Procedural Safety and Pitfalls

  • Insertion of a chest tube using a trocar is contraindicated because it significantly increases the risk of iatrogenic hemothorax, pulmonary laceration, and injury to thoracic or abdominal organs. 24
  • Clamping a bubbling chest‑tube should be avoided, as it can convert a simple pneumothorax into a tension pneumothorax. 24
  • A post‑procedure chest radiograph is required to confirm correct tube position and lung re‑expansion. 24
  • All chest tubes must be connected to a one‑way drainage system (e.g., water‑seal) that is positioned below the patient’s chest level to maintain appropriate drainage dynamics. 24

Chest Tube Indications and Management Guidelines

Pneumothorax Management

  • In clinically stable patients with a large pneumothorax (≥ 3 cm from the chest wall), initial placement of a small‑diameter chest tube (10–14 Fr) achieves successful drainage in 84–97 % of cases. 25
  • Clamping a chest tube that is actively bubbling is contraindicated because it can convert a simple pneumothorax into a tension pneumothorax, a potentially fatal complication. 25

Pleural Infection (Parapneumonic Effusion / Empyema) Management

  • The incidence of empyema following chest‑tube insertion is estimated at 1–6 %; meticulous aseptic technique is therefore essential to minimize this risk. [25][26]
  • When pleural infection is identified, empiric antibiotic therapy should be initiated immediately. 26

Systemic Anthrax with Pleural Effusion Management

  • Early and aggressive drainage is recommended for any clinically or radiographically evident pleural effusion in patients with systemic anthrax. 27
  • Chest‑tube drainage is preferred over simple thoracentesis because pleural fluid re‑accumulates rapidly after needle aspiration. 27
  • In a historical cohort of inhalational anthrax (1900–2005), 83 % of survivors received pleural drainage compared with only 9 % of non‑survivors (p < 0.001), indicating a strong association between drainage and survival. 27
  • Continuous drainage via thoracostomy using suction or a water‑seal system is advised for optimal management of anthrax‑related pleural collections. 27

Evidence‑Based Guidelines for Chest‑Tube Indication, Size Selection, Pleurodesis, and Patency Management

Indications and Size Selection for Malignant Pleural Effusions

  • Recurrent symptomatic malignant pleural effusions should be drained and treated with pleurodesis to control symptoms and prevent re‑accumulation 28.
  • For initial pleurodesis of malignant effusions, a small‑bore chest tube (10–14 F) is the recommended device because it provides adequate drainage while minimizing patient discomfort 28.

Pleurodesis Technique and Expected Outcomes

  • The standardized pleurodesis protocol includes insertion of a 10–14 F tube, complete evacuation of pleural fluid, confirmation of full lung re‑expansion on imaging, administration of analgesia, instillation of lidocaine followed by talc slurry, a 1‑hour tube clamp (with patient rotation), and subsequent suction at –20 cm H₂O; the tube can be removed within 12–72 hours if re‑expansion is maintained and 24‑hour output is <150 mL 28.
  • Talc slurry pleurodesis achieves a high success rate of approximately 93 % (153 / 165 patients) in achieving durable pleural symphysis 28.
  • Small‑bore catheters (8–16 F) provide clinical outcomes comparable to large‑bore tubes for pleurodesis, supporting their use as first‑line devices 28.
  • Rapid drainage of large pleural effusions is a risk factor for re‑expansion pulmonary edema; limiting the initial drainage volume to 1–1.5 L mitigates this complication 28.

Chest‑Tube Patency Management

  • Maintaining chest‑tube patency without breaking the sterile field is a Class I recommendation (Level B evidence); routine “milking” or manual squeezing of the tube is discouraged 29.
  • A Class IIIA recommendation (Level B) advises against any breach of sterility to aspirate clots or to manually manipulate the tube 29.
  • Active‑cleaning systems that incorporate internal guidewire loops can dissolve intraluminal clots while preserving sterility, offering a technology‑based solution for tube occlusion 29.

Clinical Benefits of Active‑Cleaning and Patency Strategies

Outcome Benefit with Active‑Cleaning System Comparative Data
Re‑exploration for bleeding 72 % reduction 5.7 % vs 1.6 % (p = 0.01)
Complete tube occlusion 89 % reduction 2 % vs 19 % (p = 0.01)
Need for additional drainage procedures (pleural effusions) 63 % reduction 8.1 % vs 22 % (p < 0.001)
Post‑operative atrial fibrillation 32 % reduction 25 % vs 37 % (p = 0.011)

29

These data support the routine adoption of sterile‑preserving patency techniques and active‑cleaning technologies to improve patient safety and reduce downstream interventions.

Management of Small Primary Spontaneous Pneumothorax in Clinically Stable Patients

Observation as First‑Line Management

  • In clinically stable adults with a primary spontaneous pneumothorax measuring less than 2 cm from the chest wall, the British Thoracic Society recommends observation alone as the preferred and safer initial management, avoiding chest‑tube insertion. 30

  • The 2023 British Thoracic Society guideline states that small pneumothoraces (< 2 cm) in stable patients can be managed without any invasive intervention, resulting in comparable clinical outcomes while minimizing procedural pain and infection risk. 30

When Chest‑Tube Drainage Is Indicated

  • For primary spontaneous pneumothorax that is large (≥ 2 cm, or ≥ 3 cm by some definitions) or when the patient becomes clinically unstable, the American College of Chest Physicians (2001 Delphi consensus) advises placement of a chest tube (16–22 Fr for stable patients, 24–28 Fr for unstable patients). 31

  • Hospital admission is required for large pneumothoraces (≥ 2 cm/≥ 3 cm) according to the American College of Chest Physicians consensus. 31

  • Chest‑tube placement becomes mandatory under any of the following conditions: clinical instability (abnormal vital signs), large pneumothorax (≥ 2–3 cm), failure of simple aspiration, or need for mechanical ventilation. 31

Evidence Supporting Observation Versus Immediate Drainage

  • The American College of Chest Physicians Delphi consensus (2001) reported occasional deaths when observation alone was used for small pneumothoraces, which led some clinicians to favor early hospitalization; however, the later 2023 British Thoracic Society guideline clarifies that observation is safer when true clinical stability is confirmed. [31][30]

Tube Size Recommendations

  • For patients who are unstable, the American College of Chest Physicians recommends using larger‑diameter tubes (24–28 Fr); for stable patients with a large pneumothorax requiring drainage, smaller tubes (16–22 Fr) are adequate. 31

Evidence‑Based Management of Primary Spontaneous Pneumothorax

Indications for Surgical Referral

  • Persistent air leak lasting more than 5–7 days despite chest‑tube drainage, a second ipsilateral pneumothorax, a first contralateral pneumothorax, synchronous bilateral pneumothorax, occupations with high recurrence risk (e.g., pilots, divers, military), presentation with tension pneumothorax, pregnancy, or spontaneous hemothorax should prompt referral for surgical intervention. 32, 33

Comparative Outcomes of Video‑Assisted Thoracoscopic Surgery (VATS) vs. Thoracotomy

  • VATS is recommended as the primary surgical approach for most pneumothorax cases; it shortens hospital stay, reduces postoperative pain and overall complications compared with thoracotomy, while maintaining a very low recurrence rate (slightly higher than thoracotomy but still minimal). 32, 33
  • Thoracotomy is reserved for patients in high‑risk occupations where the absolute lowest recurrence risk is required; it provides the lowest recurrence rate but is associated with greater morbidity than VATS. 32, 33

Surgical Techniques and Adjuncts

  • Bullectomy—stapler resection of blebs or bullae—is a standard component of operative management for pneumothorax. 33
  • Pleurodesis (talc poudrage, pleural abrasion, or partial pleurectomy) may be performed adjunctively to promote pleural symphysis and further reduce recurrence. 33
  • For patients who are unsuitable for definitive surgery but have a persistent air leak, autologous blood pleurodesis delivered via the existing chest tube is an accepted alternative. 32

Chronic Morbidity After Chest‑Tube Thoracostomy

  • Chronic chest‑wall pain and paraesthesia can persist after chest‑tube placement; clinicians should provide appropriate counseling regarding this potential long‑term complication. 32

Heimlich Valve Use in Chest Tube Drainage for Clinically Stable Pneumothorax Patients

Device Description and Mechanism

  • The Heimlich valve is a compact one‑way flutter valve that permits air and fluid to exit the pleural space while preventing backflow, offering a portable alternative to traditional underwater‑seal systems for selected pneumothorax patients who are clinically stable and ambulatory. 34

Clinical Efficacy in Primary Spontaneous Pneumothorax

  • Adding a Heimlich valve to catheter aspiration improves treatment success for primary spontaneous pneumothorax, achieving control of up to 59 % of cases when combined with suction, compared with aspiration alone. 34

Advantages Over Traditional Underwater‑Seal Systems

  • The valve eliminates the need for a bulky underwater‑seal bottle that must stay upright, thereby removing a major barrier to patient mobility during chest drainage. 34

Technical Compatibility and Implementation

  • The Heimlich valve is designed to connect directly to standard chest tubing, typically small‑bore catheters ranging from 8 F to 14 F, facilitating its use in pneumothorax management. 34

REFERENCES

4

cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax. [LINK]

American Journal of Respiratory and Critical Care Medicine, 2010

5

cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax. [LINK]

American Journal of Respiratory and Critical Care Medicine, 2010

9

cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax. [LINK]

American Journal of Respiratory and Critical Care Medicine, 2010

10

cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax. [LINK]

American Journal of Respiratory and Critical Care Medicine, 2010

14

management of malignant pleural effusions. [LINK]

American Journal of Respiratory and Critical Care Medicine, 2000

20

management of malignant pleural effusions. [LINK]

American Journal of Respiratory and Critical Care Medicine, 2000